Pnc Financial Services Group, Inc. Biogen Inc. Transaction History

Pnc Financial Services Group, Inc.

$156 Billion
Q3 2024

A detailed history of Pnc Financial Services Group, Inc. transactions in Biogen Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 23,421 shares of BIIB stock, worth $3.49 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

23,421

Previous 24,594 4.77%

Holding current value

$3.49 Million

Previous $5.7 Million 20.38%

% of portfolio

0.0%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$189.07 - $236.8 $221,779 - $277,766	-1,173 Reduced 4.77%	23,421 $4.54 Million
Q2 2024 Aug 09, 2024	BUY	$190.52 - $236.72 $1,714 - $2,130	9 Added 0.04%	24,594 $5.7 Million
Q1 2024 May 10, 2024	BUY	$212.02 - $267.71 $46,220 - $58,360	218 Added 0.89%	24,585 $5.3 Million
Q4 2023 Feb 09, 2024	SELL	$222.59 - $267.94 $166,052 - $199,883	-746 Reduced 2.97%	24,367 $6.31 Million
Q3 2023 Nov 13, 2023	SELL	$253.3 - $285.89 $613,999 - $692,997	-2,424 Reduced 8.8%	25,113 $6.45 Million
Q2 2023 Aug 11, 2023	SELL	$275.25 - $318.06 $193,776 - $223,914	-704 Reduced 2.49%	27,537 $7.84 Million
Q1 2023 May 15, 2023	SELL	$256.56 - $292.34 $106,985 - $121,905	-417 Reduced 1.46%	28,241 $7.85 Million
Q4 2022 Feb 10, 2023	SELL	$252.44 - $306.72 $67,653 - $82,200	-268 Reduced 0.93%	28,658 $7.94 Million
Q3 2022 Nov 10, 2022	SELL	$194.69 - $268.46 $87,415 - $120,538	-449 Reduced 1.53%	28,926 $7.72 Million
Q2 2022 Aug 12, 2022	SELL	$187.54 - $223.02 $1.01 Million - $1.21 Million	-5,409 Reduced 15.55%	29,375 $5.99 Million
Q1 2022 May 12, 2022	SELL	$193.77 - $244.14 $1.17 Million - $1.48 Million	-6,048 Reduced 14.81%	34,784 $7.33 Million
Q4 2021 Feb 11, 2022	SELL	$223.92 - $287.77 $1.24 Million - $1.59 Million	-5,533 Reduced 11.93%	40,832 $9.8 Million
Q3 2021 Nov 05, 2021	SELL	$282.99 - $369.05 $809,634 - $1.06 Million	-2,861 Reduced 5.81%	46,365 $13.1 Million
Q2 2021 Aug 06, 2021	SELL	$259.0 - $414.71 $2.43 Million - $3.9 Million	-9,395 Reduced 16.03%	49,226 $17 Million
Q1 2021 May 07, 2021	SELL	$242.95 - $284.63 $1.48 Million - $1.73 Million	-6,072 Reduced 9.39%	58,621 $16.4 Million
Q4 2020 Feb 12, 2021	SELL	$236.26 - $355.63 $1.62 Million - $2.43 Million	-6,841 Reduced 9.56%	64,693 $15.8 Million
Q3 2020 Nov 06, 2020	SELL	$264.77 - $305.71 $1.28 Million - $1.48 Million	-4,839 Reduced 6.34%	71,534 $20.3 Million
Q2 2020 Aug 07, 2020	SELL	$258.66 - $342.55 $1.51 Million - $2 Million	-5,845 Reduced 7.11%	76,373 $20.4 Million
Q1 2020 May 08, 2020	BUY	$268.85 - $341.04 $877,526 - $1.11 Million	3,264 Added 4.13%	82,218 $26 Million
Q4 2019 Feb 07, 2020	SELL	$220.06 - $304.07 $3.43 Million - $4.74 Million	-15,587 Reduced 16.49%	78,954 $23.4 Million
Q3 2019 Nov 08, 2019	SELL	$217.44 - $243.88 $637,534 - $715,056	-2,932 Reduced 3.01%	94,541 $22 Million
Q2 2019 Aug 09, 2019	SELL	$219.29 - $241.72 $8.4 Million - $9.26 Million	-38,312 Reduced 28.22%	97,473 $0
Q1 2019 May 10, 2019	SELL	$216.71 - $338.96 $51.3 Million - $80.2 Million	-236,739 Reduced 63.55%	135,785 $0
Q4 2018 Feb 08, 2019	SELL	$278.5 - $352.75 $518,567 - $656,820	-1,862 Reduced 0.5%	372,524 $112 Million
Q3 2018 Nov 09, 2018	SELL	$293.51 - $383.83 $1.62 Million - $2.11 Million	-5,508 Reduced 1.45%	374,386 $0
Q2 2018 Aug 10, 2018	SELL	$257.52 - $306.91 $4.03 Million - $4.8 Million	-15,649 Reduced 3.96%	379,894 $0
Q1 2018 May 11, 2018	SELL	$260.13 - $367.91 $5.34 Million - $7.55 Million	-20,522 Reduced 4.93%	395,543 $0
Q4 2017 Feb 09, 2018	SELL	$307.64 - $344.58 $4.46 Million - $5 Million	-14,499 Reduced 3.37%	416,065 $0
Q3 2017 Nov 13, 2017	BUY	$281.15 - $329.69 $121 Million - $142 Million	430,564	430,564 $0

Others Institutions Holding BIIB

# of Institutions

1,032

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.4B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.

Account

Pnc Financial Services Group, Inc. Biogen Inc. Transaction History